Hinge Health Gabriel Mecklenburg (left) and Daniel Pérez (right) co -founders.
Courtesy of hinge health
Hinge Health said in a presentation on Tuesday that he plans to raise up to $ 437 million in his next initial public offer.
The Digital Startup Physiotherapy presented its initial prospect in March, and updated the document with an expected price range for its common class A shares from $ 28 to $ 32 per share. Hinge said he plans to sell around 13.7 million shares in the offer.
According to the number of class A and class B shares in circulation after the offer, the agreement would assess the company at $ 2.42 billion in the middle of the range, although that number could be higher in a completely diluted base.
Hinge, founded in 2014, uses software to help patients treat acute musculoskeletal lesions, chronic pain and carry out rehabilitation after surgery remotely. The company was co -founded by CEO Daniel Pérez and executive president Gabriel Mecklenburg, who have experienced personal struggles with physical rehabilitation.
Three weeks after Hinge presented his initial prospect, President Donald Trump announced a radical tariff policy that immersed US markets in agitation. This volatility has caused several companies, including the online lender Klarna and the Stubhub ticket market, delay their long -awaited OPI.
Hinge is advancing anyway, and a second Digital Health startup, the Virtual Chronic Care Company Health, presented public on Friday. Both OPI will be closely observed by the digital health sector, which has been mainly devoid of public offers since 2021.
During his first quarter, Hinge said revenues increased 50% to $ 123.8 million, compared to $ 82.7 million during the same period last year. Hinge reported $ 117.3 million in revenues during his fourth quarter, 44% more than the same period in 2023.
The company plans to trade in the New York Stock Exchange under the “HNGE” Ticker symbol.
Hinge has raised more than $ 1 billion of investors, including Tiger Global Management and Coatue Management, and had an assessment of $ 6.2 billion as of October 2021, the last time the company raised external funds. The largest institutional shareholders are the insight partners and atomic risk companies, which have 19% and 15% of the shares, respectively, according to their prospect.
LOOK: OPI window that will probably open in the first half of 2026: pitchbook
